Trials / Completed
CompletedNCT05219994
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- University of Missouri-Columbia · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Our overall goal is to advance our understanding of the contribution of the carotid body chemoreceptors in glucose regulation and the development of type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hyperoxia Exposure | 2 hours of hyperoxia exposure during OGTT |
| OTHER | Normoxia Exposure | 2 hours of normoxia exposure during OGTT |
Timeline
- Start date
- 2020-09-09
- Primary completion
- 2023-05-10
- Completion
- 2023-05-10
- First posted
- 2022-02-02
- Last updated
- 2023-07-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05219994. Inclusion in this directory is not an endorsement.